A clinical trial out of Memorial Sloan Kettering Cancer Center has set the cancer community abuzz after it showed a 100 percent success rate among the first 14 participants who completed treatment.
Non-Hispanic Black men have the worst colorectal cancer survival rates of any demographic group, and they are less likely than their non-Hispanic White counterparts to get screened.
Whether Dr. Hitchins’ research will ultimately produce a new screening test remains to be seen, but the progress made toward that end has relied greatly on the Alliance’s support.
This new technology could refine the prognosis of stage II and some low-risk stage III colon cancer patients and provide doctors with additional information when making decisions about chemotherapy treatment.
If there is one common theme in all of the literature and scientific papers, it is that cannabis and cannabinoids enhance the benefits of conventional treatment for side effect management.
Meet Project Cure CRC researcher Kevin Van der Jeught, whose mRNA-based immunotherapy research aims to unlock new treatments for colorectal cancer patients.
The 2025 ASCO Annual Meeting featured several important studies that could change how colorectal cancer is treated, including a pivotal study for BRAF V600E patients.
Uncover key survey findings on the unmet psychosocial and physical needs of colorectal cancer patients and survivors, and learn how the Alliance is shaping better care.
Evan Daniels is no stranger to the presence of cancer in his life. His father, Robert Daniels, was diagnosed with stage II colon cancer when Evan was just eight years old. Fortunately, Robert’s disease was caught early, and he was able to watch Evan grow.
Learn about The Cancer Promise initiative and how political candidates can pledge to support cancer research, prevention, and care policies. Make your voice heard this election.
This bipartisan legislation aims to improve participation in clinical trials by addressing major barriers such as non-medical expenses, trial location accessibility, diverse participation, and financial implications for patients.
The Colorectal Cancer Alliance’s philanthropic research fund, Project Cure CRC, has announced another awardee. Yekaterina Zaytseva, PhD, of the University of Kentucky will receive $200,000 over two years.